These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
442 related articles for article (PubMed ID: 32017379)
1. A Multi-action and Multi-target Ru Karges J; Yempala T; Tharaud M; Gibson D; Gasser G Angew Chem Int Ed Engl; 2020 Apr; 59(18):7069-7075. PubMed ID: 32017379 [TBL] [Abstract][Full Text] [Related]
2. A Cancer Cell-Selective and Low-Toxic Bifunctional Heterodinuclear Pt(IV)-Ru(II) Anticancer Prodrug. Ma L; Lin X; Li C; Xu Z; Chan CY; Tse MK; Shi P; Zhu G Inorg Chem; 2018 Mar; 57(5):2917-2924. PubMed ID: 29436828 [TBL] [Abstract][Full Text] [Related]
3. Insights into the anticancer photodynamic activity of Ir(III) and Ru(II) polypyridyl complexes bearing β-carboline ligands. Sanz-Villafruela J; Bermejo-Casadesus C; Zafon E; Martínez-Alonso M; Durá G; Heras A; Soriano-Díaz I; Giussani A; Ortí E; Tebar F; Espino G; Massaguer A Eur J Med Chem; 2024 Oct; 276():116618. PubMed ID: 38972079 [TBL] [Abstract][Full Text] [Related]
4. Design of a Tris-Heteroleptic Ru(II) Complex with Red-Light Excitation and Remarkably Improved Photobiological Activity. Li S; Zhao J; Wang X; Xu G; Gou S; Zhao Q Inorg Chem; 2020 Aug; 59(15):11193-11204. PubMed ID: 32702972 [TBL] [Abstract][Full Text] [Related]
5. Ruthenium(II) complexes as bioorthogonal two-photon photosensitizers for tumour-specific photodynamic therapy against triple-negative breast cancer cells. Lin M; Zou S; Liao X; Chen Y; Luo D; Ji L; Chao H Chem Commun (Camb); 2021 May; 57(36):4408-4411. PubMed ID: 33949487 [TBL] [Abstract][Full Text] [Related]
6. Ru(II) Polypyridine Complex-Functionalized Mesoporous Silica Nanoparticles as Photosensitizers for Cancer Targeted Photodynamic Therapy. Karges J; Díaz-García D; Prashar S; Gómez-Ruiz S; Gasser G ACS Appl Bio Mater; 2021 May; 4(5):4394-4405. PubMed ID: 35006851 [TBL] [Abstract][Full Text] [Related]
7. A mitochondria-targeting dinuclear Ir-Ru complex as a synergistic photoactivated chemotherapy and photodynamic therapy agent against cisplatin-resistant tumour cells. Zhang C; Guan R; Liao X; Ouyang C; Rees TW; Liu J; Chen Y; Ji L; Chao H Chem Commun (Camb); 2019 Oct; 55(83):12547-12550. PubMed ID: 31576841 [TBL] [Abstract][Full Text] [Related]
8. Evaluating the mechanisms of action and subcellular localization of ruthenium(II)-based photosensitizers. Mo J; Mai Le NP; Priefer R Eur J Med Chem; 2021 Dec; 225():113770. PubMed ID: 34403979 [TBL] [Abstract][Full Text] [Related]
10. π-Expansive Heteroleptic Ruthenium(II) Complexes as Reverse Saturable Absorbers and Photosensitizers for Photodynamic Therapy. Wang L; Yin H; Jabed MA; Hetu M; Wang C; Monro S; Zhu X; Kilina S; McFarland SA; Sun W Inorg Chem; 2017 Mar; 56(6):3245-3259. PubMed ID: 28263079 [TBL] [Abstract][Full Text] [Related]
11. Ruthenium Complexes as Anticancer Agents: A Brief History and Perspectives. Lee SY; Kim CY; Nam TG Drug Des Devel Ther; 2020; 14():5375-5392. PubMed ID: 33299303 [TBL] [Abstract][Full Text] [Related]
12. Catch and Release Photosensitizers: Combining Dual-Action Ruthenium Complexes with Protease Inactivation for Targeting Invasive Cancers. Arora K; Herroon M; Al-Afyouni MH; Toupin NP; Rohrabaugh TN; Loftus LM; Podgorski I; Turro C; Kodanko JJ J Am Chem Soc; 2018 Oct; 140(43):14367-14380. PubMed ID: 30278123 [TBL] [Abstract][Full Text] [Related]
13. A novel ruthenium polypyridyl complex for the selective imaging and photodynamic targeting of the Golgi apparatus. Zhao F; Wang W; Wu W Dalton Trans; 2021 Mar; 50(10):3536-3541. PubMed ID: 33599670 [TBL] [Abstract][Full Text] [Related]
14. A biotinylated ruthenium(ii) photosensitizer for tumor-targeted two-photon photodynamic therapy. Li J; Zeng L; Xiong K; Rees TW; Jin C; Wu W; Chen Y; Ji L; Chao H Chem Commun (Camb); 2019 Sep; 55(73):10972-10975. PubMed ID: 31453611 [TBL] [Abstract][Full Text] [Related]
15. Photophysical Properties and Photobiological Activities of Ruthenium(II) Complexes Bearing π-Expansive Cyclometalating Ligands with Thienyl Groups. McCain J; Colón KL; Barrett PC; Monro SMA; Sainuddin T; Roque Iii J; Pinto M; Yin H; Cameron CG; McFarland SA Inorg Chem; 2019 Aug; 58(16):10778-10790. PubMed ID: 31386351 [TBL] [Abstract][Full Text] [Related]
16. Ruthenium-Cathepsin Inhibitor Conjugates for Green Light-Activated Photodynamic Therapy and Photochemotherapy. Denison M; Garcia SP; Ullrich A; Podgorski I; Gibson H; Turro C; Kodanko JJ Inorg Chem; 2024 Apr; 63(17):7973-7983. PubMed ID: 38616353 [TBL] [Abstract][Full Text] [Related]
17. Rational design of type I photosensitizers based on Ru(ii) complexes for effective photodynamic therapy under hypoxia. Liu X; Li G; Xie M; Guo S; Zhao W; Li F; Liu S; Zhao Q Dalton Trans; 2020 Aug; 49(32):11192-11200. PubMed ID: 32748922 [TBL] [Abstract][Full Text] [Related]
18. Increased Lipophilicity of Halogenated Ruthenium(II) Polypyridyl Complexes Leads to Decreased Phototoxicity in vitro when Used as Photosensitizers for Photodynamic Therapy. Roy S; Colombo E; Vinck R; Mari C; Rubbiani R; Patra M; Gasser G Chembiochem; 2020 Oct; 21(20):2966-2973. PubMed ID: 32473056 [TBL] [Abstract][Full Text] [Related]
19. Polymeric Encapsulation of a Ru(II)-Based Photosensitizer for Folate-Targeted Photodynamic Therapy of Drug Resistant Cancers. Karges J; Tharaud M; Gasser G J Med Chem; 2021 Apr; 64(8):4612-4622. PubMed ID: 33818111 [TBL] [Abstract][Full Text] [Related]
20. Heterodinuclear Pt(iv)-Ru(ii) anticancer prodrugs to combat both drug resistance and tumor metastasis. Ma L; Ma R; Wang Z; Yiu SM; Zhu G Chem Commun (Camb); 2016 Sep; 52(71):10735-8. PubMed ID: 27506281 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]